Lucía Gandullo Sánchez
The Francis Crick Institute
10 papers found
Refreshing results…
An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs
UploadHER3 in cancer: from the bench to the bedside
Download from doi.orgAntitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer
Download from doi.orgNovel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs
Download from doi.orgGeneration of Antibody-Drug Conjugate Resistant Models
Download from doi.orgAltered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma
Download from link.springer.comHER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Download from onlinelibrary.wiley.comMissing publications? Search for publications with a matching author name.